Skip to main content
. 2021 Jun 29;12:3889. doi: 10.1038/s41467-021-24151-3

Fig. 2. Transport of LMW/LPSA drugs by CH1 via the TM7/TM8 groove.

Fig. 2

a Side-view of the AcrB trimer with the TM8/PC2 tunnel of the L2 protomer (blue) starting from the TM7/TM8 groove to the access pocket (AP), and ending at the entrance of the (closed) deep binding pocket (DBP) underneath the switch loop (magenta). b DDM (carbon, black; oxygen, red) binding to the TM8/PC2 tunnel with the tilted TM8 (magenta) and c-loop (green). The Polder electron density map (green mesh) assigned to DDM is contoured at 4.0 σ. c Conformational changes of tilted TM8/c-loop (L protomer, magenta; L2: red) and PC1/PC2 subdomains (L, orange; L2: yellow). Inset: DDM binding to the L protomer (white), L2 protomer (black), and DDM bound to an AcrB/erythromycin complex (PDB ID: 4ZJL16) (cyan). d Binding of fusidic acid (FUA) to the TM7/TM8 groove of AcrB-Phe380Ala. Inset: Polder electron density map (green mesh) assigned to FUA (carbon, black; oxygen, red) is contoured at 4.2 σ. e Binding of FUA to the TM7/TM8 groove in the TFI-LIG2 (fully induced) protomer (carbon, black; oxygen, red). Polder map (green mesh) of FUA is contoured at 5.0 σ. f Superimposition of the TMD (TM5, TM7-10) of FUA bound to AcrB-Phe380Ala (yellow) and the AcrB TFI-LIG2 (orange) T protomers.